Drug wholesaler Farmaceutica Remedia reported considerably weaker financial results in the first quarter of 2026 against the year-earlier period: consolidated turnover slid 11% to RON168.3 million, while net profit plummeted from RON2.8 million to RON670,683, a collapse of around 76%.